Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Bioequivalence Study Bevacizumab Biosimilar (BEVZ92) Versus Bevacizumab (AVASTIN®) in First-line Treatment mCRC Patients

mAbxience Research S.L. · 2014
ClinicalTrials.gov · Datasets · License: Public Domain · 2014
Open Source ↗
colorectalcancercomparabilityfirst
metastatic colorectal cancer (mcrc), colorectal cancer, metastatic, first-line treatment, comparability, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 833440
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.